BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26756941)

  • 1. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH; Lee JM; Klotz E; Han JK
    Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
    Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV; Holalkere NS; Mueller PR; Zhu AX
    Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
    Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method.
    Lv P; Lin XZ; Li J; Li W; Chen K
    Radiology; 2011 Jun; 259(3):720-9. PubMed ID: 21357524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative hepatic CT perfusion measurement: comparison of Couinaud's hepatic segments with dual-source 128-slice CT.
    Wang X; Xue HD; Jin ZY; Su BY; Li Z; Sun H; Chen Y; Liu W
    Eur J Radiol; 2013 Feb; 82(2):220-6. PubMed ID: 23083523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Meloni F; Invernizzi F; Valsecchi MG; Fazio F
    J Comput Assist Tomogr; 2008; 32(6):855-8. PubMed ID: 19204443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
    Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic study of primary hepatocellular carcinoma evolved from viral-induced cirrhosis using CT perfusion imaging].
    Zhang Q; Zhang XL; Zhang YZ; Cheng GX; Chen ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1986-9. PubMed ID: 19033109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration.
    Nakashige A; Horiguchi J; Tamura A; Asahara T; Shimamoto F; Ito K
    Br J Radiol; 2004 Sep; 77(921):728-34. PubMed ID: 15447957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT.
    Kim KW; Lee JM; Kim JH; Klotz E; Kim HC; Han JK; Choi BI
    AJR Am J Roentgenol; 2011 Jan; 196(1):102-8. PubMed ID: 21178053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
    Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
    Kim KS; Lee JM; Kim SH; Kim KW; Kim SJ; Cho SH; Han JK; Choi BI
    Invest Radiol; 2010 Mar; 45(3):149-57. PubMed ID: 20142749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion.
    Ippolito D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Abdom Imaging; 2013 Jun; 38(3):502-10. PubMed ID: 22743839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.